Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
vaccination protocol to induce specific immune responses against melanoma associated antigens
by intradermal injections of mRNA coding for the corresponding antigen